Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0750
+0.0050 (7.14%)
Sep 17, 2026, 5:16 PM EST
Lobe Sciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
25.47M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | - | - | - |
| Aug 31, 2024 | 136.21K | -704.33K | -83.80% |
| Aug 31, 2023 | 840.53K | - | - |
| Aug 31, 2022 | - | - | - |
| Aug 31, 2021 | - | - | - |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Telescope Innovations | 7.30M |
| Devonian Health Group | 3.00M |
| Pharmala Biotech Holdings | 1.27M |
| Onco-Innovations | 90.88K |
| The More Life Company | 70.00K |
| Alzai Health | 27.04K |
Lobe Sciences News
- 5 days ago - Lobe Sciences to Present Low-Dose L-130 Clinical Data at 9th Neuropsychiatric Drug Development Summit - Accesswire
- 5 days ago - Lobe Sciences to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto - Newsfile Corp
- 19 days ago - Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement - Accesswire
- 22 days ago - Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement - Accesswire
- 22 days ago - Lobe Sciences Expands Leadership Team with New CFO Appointment - Accesswire
- 4 weeks ago - Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement - Accesswire
- 4 weeks ago - Lobe Sciences Reports Third Quarter 2026 Financial Results - Accesswire
- 5 weeks ago - Lobe Sciences Ltd. Announces Non-Brokered Private Placement - Accesswire